{"product_id":"gwu-idbr-infectious-disease-board-review-course-2025-lecture-pdf","title":"GWU IDBR Infectious Disease Board Review Course 2025 (Lecture +PDF)","description":"\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\r\n\u003cstrong\u003eIDBR 2025 (Lecture +PDF)  WARNING: The QBank section has 6 question sections with over 500 questions, with answers and detailed explanations, handcrafted into word files and converted to PDF by  . Includes access links to 8 lectures 2025 Infectious Disease Board Review Course Primers and Study Guides 8 PDF\u003c\/strong\u003e\r\n\u003cp data-start=\"297\" data-end=\"724\"\u003eThe \u003cem data-start=\"323\" data-end=\"390\"\u003eGWU Infectious Disease Board Review Course 2025\u003c\/em\u003e is a top-tier, all-in-one preparation bundle designed for physicians pursuing the infectious disease board certification. Featuring expertly crafted video lectures and a comprehensive question bank, this package offers both in-depth understanding and effective exam strategies—available entirely online to accommodate busy schedules.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"726\" data-end=\"729\"\u003e\r\n\u003cp data-start=\"731\" data-end=\"756\"\u003e\u003cstrong data-start=\"731\" data-end=\"754\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"757\" data-end=\"1386\"\u003e\r\n \t\u003cli data-start=\"757\" data-end=\"974\"\u003e\r\n\u003cp data-start=\"759\" data-end=\"974\"\u003eCore concepts and high-impact updates across the field of infectious diseases, including antimicrobial therapy, HIV\/AIDS management, tropical medicine, endocarditis, opportunistic infections, and infection control\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"975\" data-end=\"1155\"\u003e\r\n\u003cp data-start=\"977\" data-end=\"1155\"\u003eEffective strategies and diagnostic frameworks for challenging syndromes—such as sepsis, fever of unknown origin, transplant-associated infections, and antimicrobial resistance\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1156\" data-end=\"1272\"\u003e\r\n\u003cp data-start=\"1158\" data-end=\"1272\"\u003eEvidence-based best practices and guidelines for patient-centered care in both inpatient and outpatient settings\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1273\" data-end=\"1386\"\u003e\r\n\u003cp data-start=\"1275\" data-end=\"1386\"\u003eTargeted board preparation with reinforced explanations through realistic, case-based multiple-choice questions\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"1388\" data-end=\"1391\"\u003e\r\n\u003cp data-start=\"1393\" data-end=\"1412\"\u003e\u003cstrong data-start=\"1393\" data-end=\"1410\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"1413\" data-end=\"1899\"\u003e\r\n \t\u003cli data-start=\"1413\" data-end=\"1533\"\u003e\r\n\u003cp data-start=\"1415\" data-end=\"1533\"\u003e\u003cstrong data-start=\"1415\" data-end=\"1426\"\u003eFormat:\u003c\/strong\u003e Fully on-demand online delivery combining expert video lectures with a robust, interactive question bank\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1534\" data-end=\"1712\"\u003e\r\n\u003cp data-start=\"1536\" data-end=\"1712\"\u003e\u003cstrong data-start=\"1536\" data-end=\"1551\"\u003eComponents:\u003c\/strong\u003e Includes high-yield lecture modules, a question bank with detailed explanations, and downloadable study materials tailored to infectious disease board content\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1713\" data-end=\"1818\"\u003e\r\n\u003cp data-start=\"1715\" data-end=\"1818\"\u003e\u003cstrong data-start=\"1715\" data-end=\"1726\"\u003eAccess:\u003c\/strong\u003e Available across devices 24\/7, with flexible review timelines to suit your learning needs\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"1901\" data-end=\"1904\"\u003e\r\n\u003cp data-start=\"1906\" data-end=\"2152\"\u003e\u003cstrong data-start=\"1906\" data-end=\"1927\"\u003eWho Should Attend\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp data-start=\"1906\" data-end=\"2152\"\u003eIdeal for infectious disease fellows, physicians preparing for board certification or recertification, advanced practice providers, and other healthcare professionals seeking a structured, high-yield review in ID medicine.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"2154\" data-end=\"2157\"\u003e\r\n\u003cp data-start=\"2159\" data-end=\"2504\"\u003e\u003cstrong data-start=\"2159\" data-end=\"2173\"\u003eWhy Attend\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp data-start=\"2159\" data-end=\"2504\"\u003eThis course is your most efficient and effective path to board success—combining comprehensive content, active learning, and flexible delivery.\u003c\/p\u003e\r\n \r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003ch2 data-start=\"153\" data-end=\"207\"\u003e\u003cstrong data-start=\"156\" data-end=\"207\"\u003eDay 1 – Core Concepts \u0026amp; Immunocompromised Hosts\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul data-start=\"208\" data-end=\"764\"\u003e\r\n \t\u003cli data-start=\"208\" data-end=\"235\"\u003e\r\n\u003cp data-start=\"210\" data-end=\"235\"\u003eIntroduction \u0026amp; overview\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"236\" data-end=\"276\"\u003e\r\n\u003cp data-start=\"238\" data-end=\"276\"\u003eMicrobiology essentials for the exam\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"277\" data-end=\"359\"\u003e\r\n\u003cp data-start=\"279\" data-end=\"359\"\u003ePrinciples of antimicrobial therapy: toxicities, PK\/PD, drug–drug interactions\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"360\" data-end=\"431\"\u003e\r\n\u003cp data-start=\"362\" data-end=\"431\"\u003eAntibacterial drugs I – approach to resistant gram-negative bacilli\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"432\" data-end=\"451\"\u003e\r\n\u003cp data-start=\"434\" data-end=\"451\"\u003eAntiviral drugs\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"452\" data-end=\"542\"\u003e\r\n\u003cp data-start=\"454\" data-end=\"542\"\u003eRespiratory viral infections including influenza (immunocompetent \u0026amp; immunocompromised)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"543\" data-end=\"570\"\u003e\r\n\u003cp data-start=\"545\" data-end=\"570\"\u003eSARS-CoV-2 and COVID-19\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"571\" data-end=\"620\"\u003e\r\n\u003cp data-start=\"573\" data-end=\"620\"\u003eImmunizations: domestic, travel, occupational\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"621\" data-end=\"673\"\u003e\r\n\u003cp data-start=\"623\" data-end=\"673\"\u003eInfections in hematopoietic stem cell recipients\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"674\" data-end=\"722\"\u003e\r\n\u003cp data-start=\"676\" data-end=\"722\"\u003eInfections in the neutropenic cancer patient\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"723\" data-end=\"764\"\u003e\r\n\u003cp data-start=\"725\" data-end=\"764\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"766\" data-end=\"769\"\u003e\r\n\r\n\u003ch2 data-start=\"771\" data-end=\"822\"\u003e\u003cstrong data-start=\"774\" data-end=\"822\"\u003eDay 2 – Hepatitis, GI \u0026amp; Parasitic Infections\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul data-start=\"823\" data-end=\"1186\"\u003e\r\n \t\u003cli data-start=\"823\" data-end=\"842\"\u003e\r\n\u003cp data-start=\"825\" data-end=\"842\"\u003eAcute hepatitis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"843\" data-end=\"864\"\u003e\r\n\u003cp data-start=\"845\" data-end=\"864\"\u003eChronic hepatitis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"865\" data-end=\"903\"\u003e\r\n\u003cp data-start=\"867\" data-end=\"903\"\u003eClinical immunology \u0026amp; host defense\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"904\" data-end=\"928\"\u003e\r\n\u003cp data-start=\"906\" data-end=\"928\"\u003eCMV, EBV, HHV6, HHV8\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"929\" data-end=\"981\"\u003e\r\n\u003cp data-start=\"931\" data-end=\"981\"\u003eAntibacterial drugs II – gram-positive organisms\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"982\" data-end=\"1011\"\u003e\r\n\u003cp data-start=\"984\" data-end=\"1011\"\u003eGI infections Part I \u0026amp; II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1012\" data-end=\"1047\"\u003e\r\n\u003cp data-start=\"1014\" data-end=\"1047\"\u003eHelicobacter and Clostridioides\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1048\" data-end=\"1083\"\u003e\r\n\u003cp data-start=\"1050\" data-end=\"1083\"\u003eSkin and soft tissue infections\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1084\" data-end=\"1118\"\u003e\r\n\u003cp data-start=\"1086\" data-end=\"1118\"\u003eProtozoa of clinical relevance\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1119\" data-end=\"1144\"\u003e\r\n\u003cp data-start=\"1121\" data-end=\"1144\"\u003eWorms you should know\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1145\" data-end=\"1186\"\u003e\r\n\u003cp data-start=\"1147\" data-end=\"1186\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"1188\" data-end=\"1191\"\u003e\r\n\r\n\u003ch2 data-start=\"1193\" data-end=\"1249\"\u003e\u003cstrong data-start=\"1196\" data-end=\"1249\"\u003eDay 3 – Fungal, Mycobacterial \u0026amp; Zoonotic Diseases\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul data-start=\"1250\" data-end=\"1677\"\u003e\r\n \t\u003cli data-start=\"1250\" data-end=\"1292\"\u003e\r\n\u003cp data-start=\"1252\" data-end=\"1292\"\u003eDeep mycoses (normal \u0026amp; abnormal hosts)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1293\" data-end=\"1336\"\u003e\r\n\u003cp data-start=\"1295\" data-end=\"1336\"\u003eNocardiosis, Actinomycosis, Rhodococcus\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1337\" data-end=\"1396\"\u003e\r\n\u003cp data-start=\"1339\" data-end=\"1396\"\u003eTuberculosis (immunocompetent \u0026amp; immunosuppressed hosts)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1397\" data-end=\"1413\"\u003e\r\n\u003cp data-start=\"1399\" data-end=\"1413\"\u003eLyme disease\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1414\" data-end=\"1461\"\u003e\r\n\u003cp data-start=\"1416\" data-end=\"1461\"\u003eTicks, mites, lice and transmitted diseases\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1462\" data-end=\"1474\"\u003e\r\n\u003cp data-start=\"1464\" data-end=\"1474\"\u003eZoonoses\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1475\" data-end=\"1488\"\u003e\r\n\u003cp data-start=\"1477\" data-end=\"1488\"\u003ePneumonia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1489\" data-end=\"1558\"\u003e\r\n\u003cp data-start=\"1491\" data-end=\"1558\"\u003eSexually transmitted infections (genital ulcers; other syndromes)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1559\" data-end=\"1609\"\u003e\r\n\u003cp data-start=\"1561\" data-end=\"1609\"\u003eSyndromes in the ICU relevant to ID physicians\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1610\" data-end=\"1635\"\u003e\r\n\u003cp data-start=\"1612\" data-end=\"1635\"\u003eHospital epidemiology\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1636\" data-end=\"1677\"\u003e\r\n\u003cp data-start=\"1638\" data-end=\"1677\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"1679\" data-end=\"1682\"\u003e\r\n\r\n\u003ch2 data-start=\"1684\" data-end=\"1717\"\u003e\u003cstrong data-start=\"1687\" data-end=\"1717\"\u003eDay 4 – HIV \u0026amp; Retroviruses\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul data-start=\"1718\" data-end=\"2216\"\u003e\r\n \t\u003cli data-start=\"1718\" data-end=\"1735\"\u003e\r\n\u003cp data-start=\"1720\" data-end=\"1735\"\u003eHIV diagnosis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1736\" data-end=\"1759\"\u003e\r\n\u003cp data-start=\"1738\" data-end=\"1759\"\u003eHIV drug resistance\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1760\" data-end=\"1818\"\u003e\r\n\u003cp data-start=\"1762\" data-end=\"1818\"\u003eAntiretroviral therapy (general \u0026amp; special populations)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1819\" data-end=\"1869\"\u003e\r\n\u003cp data-start=\"1821\" data-end=\"1869\"\u003eHIV-associated opportunistic infections I \u0026amp; II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1870\" data-end=\"1917\"\u003e\r\n\u003cp data-start=\"1872\" data-end=\"1917\"\u003eNon–AIDS-defining complications of HIV\/AIDS\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1918\" data-end=\"1985\"\u003e\r\n\u003cp data-start=\"1920\" data-end=\"1985\"\u003eClinical manifestations of retroviral diseases and slow viruses\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"1986\" data-end=\"2004\"\u003e\r\n\u003cp data-start=\"1988\" data-end=\"2004\"\u003eHerpes simplex\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2005\" data-end=\"2037\"\u003e\r\n\u003cp data-start=\"2007\" data-end=\"2037\"\u003eBacterial \u0026amp; viral meningitis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2038\" data-end=\"2089\"\u003e\r\n\u003cp data-start=\"2040\" data-end=\"2089\"\u003ePharyngitis syndromes (including Group A strep)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2090\" data-end=\"2130\"\u003e\r\n\u003cp data-start=\"2092\" data-end=\"2130\"\u003eSyndromes masquerading as infections\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2131\" data-end=\"2174\"\u003e\r\n\u003cp data-start=\"2133\" data-end=\"2174\"\u003ePhoto review session: board-style cases\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2175\" data-end=\"2216\"\u003e\r\n\u003cp data-start=\"2177\" data-end=\"2216\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"2218\" data-end=\"2221\"\u003e\r\n\r\n\u003ch2 data-start=\"2223\" data-end=\"2274\"\u003e\u003cstrong data-start=\"2226\" data-end=\"2274\"\u003eDay 5 – Systemic \u0026amp; Device-Related Infections\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul data-start=\"2275\" data-end=\"2707\"\u003e\r\n \t\u003cli data-start=\"2275\" data-end=\"2334\"\u003e\r\n\u003cp data-start=\"2277\" data-end=\"2334\"\u003eEndocarditis (native \u0026amp; prosthetic valves, pacers, VADs)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2335\" data-end=\"2362\"\u003e\r\n\u003cp data-start=\"2337\" data-end=\"2362\"\u003eBone \u0026amp; joint infections\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2363\" data-end=\"2399\"\u003e\r\n\u003cp data-start=\"2365\" data-end=\"2399\"\u003eStaphylococcus aureus infections\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2400\" data-end=\"2457\"\u003e\r\n\u003cp data-start=\"2402\" data-end=\"2457\"\u003eNontuberculous mycobacteria (normal \u0026amp; abnormal hosts)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2458\" data-end=\"2498\"\u003e\r\n\u003cp data-start=\"2460\" data-end=\"2498\"\u003eInfections in solid organ recipients\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2499\" data-end=\"2552\"\u003e\r\n\u003cp data-start=\"2501\" data-end=\"2552\"\u003eEncephalitis (including West Nile virus \u0026amp; rabies)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2553\" data-end=\"2577\"\u003e\r\n\u003cp data-start=\"2555\" data-end=\"2577\"\u003ePenicillin allergies\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2578\" data-end=\"2614\"\u003e\r\n\u003cp data-start=\"2580\" data-end=\"2614\"\u003eAntifungal drugs (core concepts)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2615\" data-end=\"2665\"\u003e\r\n\u003cp data-start=\"2617\" data-end=\"2665\"\u003e“Kitchen sink” syndromes not covered elsewhere\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2666\" data-end=\"2707\"\u003e\r\n\u003cp data-start=\"2668\" data-end=\"2707\"\u003eDaily question previews, polling, Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"2709\" data-end=\"2712\"\u003e\r\n\r\n\u003ch2 data-start=\"2714\" data-end=\"2752\"\u003e\u003cstrong data-start=\"2717\" data-end=\"2752\"\u003eOnline-Only (OL) Bonus Lectures\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul data-start=\"2753\" data-end=\"3227\"\u003e\r\n \t\u003cli data-start=\"2753\" data-end=\"2823\"\u003e\r\n\u003cp data-start=\"2755\" data-end=\"2823\"\u003eHow to prepare for certification \u0026amp; recertification (including LKA)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2824\" data-end=\"2841\"\u003e\r\n\u003cp data-start=\"2826\" data-end=\"2841\"\u003eBootcamp: HIV\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2842\" data-end=\"2866\"\u003e\r\n\u003cp data-start=\"2844\" data-end=\"2866\"\u003eBootcamp: Transplant\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2867\" data-end=\"2896\"\u003e\r\n\u003cp data-start=\"2869\" data-end=\"2896\"\u003eStatistics for the boards\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2897\" data-end=\"2942\"\u003e\r\n\u003cp data-start=\"2899\" data-end=\"2942\"\u003eAntibacterial drugs not covered elsewhere\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2943\" data-end=\"2994\"\u003e\r\n\u003cp data-start=\"2945\" data-end=\"2994\"\u003eTreating antimicrobial-resistant infections III\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"2995\" data-end=\"3042\"\u003e\r\n\u003cp data-start=\"2997\" data-end=\"3042\"\u003eHIV-associated opportunistic infections III\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"3043\" data-end=\"3115\"\u003e\r\n\u003cp data-start=\"3045\" data-end=\"3115\"\u003eBrain abscess, cavernous sinus thrombosis, subdural\/epidural empyema\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"3116\" data-end=\"3167\"\u003e\r\n\u003cp data-start=\"3118\" data-end=\"3167\"\u003eInfections of the urinary tract (upper \u0026amp; lower)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"3168\" data-end=\"3207\"\u003e\r\n\u003cp data-start=\"3170\" data-end=\"3207\"\u003eEpididymitis, orchitis, prostatitis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli data-start=\"3208\" data-end=\"3227\"\u003e\r\n\u003cp data-start=\"3210\" data-end=\"3227\"\u003eEven more worms\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":42954687774818,"sku":"MED-AMB08202","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Infectious-Disease-Board-Review-Course-2025-1.png?v=1779382476","url":"https:\/\/meducourse.com\/products\/gwu-idbr-infectious-disease-board-review-course-2025-lecture-pdf","provider":"Meducourse","version":"1.0","type":"link"}